Sessie 3: Lange liggers

Lange Liggers op de IC & MC MC symposium 2010 15 maart 2010

inhoud ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ASSOCIATIES? ,[object Object],[object Object],[object Object],[object Object],[object Object]

Definitie? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

wat is jullie schatting? ,[object Object],[object Object],[object Object],[object Object],[object Object]

Literatuur Naam Jaar IC type N (%) LL def. Sterfte IC (%) Sterfte ZH (%) Sterfte FU (%) Factoren mortaliteit Opmerking Gersbach Zwitserland 06 Card 194 (10) > 5 dg 9 14 25 Retros 3 jr Thuis; QOL G/M/S 119/32/14 na Soares Spanje 08 Onco 163 (15) > 21dg 50 60 MOF, LFT, premor st Cabrera Spanje 08 C,Ch,M 42 (4,9) >30dg > 70 jr LFT, premor st, APACHE, MOF < 70 = > 70 jr LOS: beademing Retrosp: 6 jr 15 jr lang oversterfte post IC Delle Karth Oostenrijk 06 C,M 135(10) > 30 dg 24 30 61 CVVH (1 jr post IC) Retrosp 4 jr LL grotere sterfte kans post ZH Barthel gga Hariharan Barbados 06 Ch 56(13) >14 dg LFT, APACHE Retrosp 3 jr LL 6x duurder 30% = MC pn Laupland Canada 06 C, Ch, M (4) > 14 dg 25 33 Retrosp 3 jr Mort-IC LL : KL = 2:1 Friedrich Canada 06 C,Ch, M 182(8) > 30dg 32 48 56 LFT, immuun, > 90dg beadm, > 3dg inotro, CVVH FU = 6 mnd Combes Frankrijk 03 C,Ch, M 347 > 14dg 44 44 59 IC :NYHA>2, BK+, immuun, SS, CVVH, postIC: LFT, immuun, bead > 35 dg FU = 1-35 mnd QOL-3jr  ARDS-pulm  Pajonk Duitsland 02 Ch 101 > 30dg 31 55 IC: LFT, opname diagnose, MOF Post IC LFT, premorb, opname diagnose FU: 35  14 mnd Trauma = jong 2/3 goed, 2/3 ernstige handicaps Williams VS 02 C 49 (3,8) > 14 dgn 28,5 38 Mort-IC LL : KL = 28,5 : 5,3% MODS>6 op dg 14= †

Conclusies (I) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Conclusies (II) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ZGV Lange Liggers 2009 Totaal patienten IC 342 < 14 dagen IC 311 14 dagen IC 31 (9 %)

Lange Liggers IC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MC 31 patienten 14 (45%) 7 (23%) overleden 6 (19%) ander ZH 3 (10%) verpl.huis of ic 1 (3%) CCU

IC patienten LL ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Post IC patienten op MC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

LOS (= opname duur) beinvloedende factoren Pre-IC - Bijsturen - Preventie IC-opname - Zo kort mogelijk - ? Standaard info IC/MC? End of Life - kwaliteit EoL 

Continuiteit Zorg ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Holistische benadering ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Follow Up zorg ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Medisch inhoudelijk ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Opname = ontslag plannen ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

LL-Overleg ZGV ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Post IC revalidatie UK ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Table 2 Symptoms from the functional assessment that may indicate the presence of physical and non-physical morbidity Physical dimensions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Programma post IC revalidatieUK ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Advies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Sessie 3: Lange liggers

Recommended

Recommended

More Related Content

Similar to Sessie 3: Lange liggers

Similar to Sessie 3: Lange liggers (17)

More from Medium Care Symposium

More from Medium Care Symposium (7)

Sessie 3: Lange liggers